Nifeviroc is regarded as a catalyst to upgrade the effect of the cokctail.
Following the agreement with Avexa, Targetdrug will possess the rights for developing Nifeviroc in China. Avexa will take charge of post-research expenses, develop it in the international marketplace and share global benefits with Targetdrug.
looks good!
seek expert advice
- Forums
- ASX - By Stock
- AVX
- nifeviroc
nifeviroc
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online